Effect of atmospheric gas plasmas on cancer cell signaling

Area of Science:

• Biomedical Engineering
• Oncology
• Plasma Physics

Background:

• Conventional cancer treatments cause significant side effects due to non-specific cell killing.
• Atmospheric gas plasmas (AGP) present a novel therapeutic approach with demonstrated tumor-specific effects in preclinical models.
• The precise mechanisms underlying AGP's selective cancer cell toxicity remain incompletely understood.

Purpose of the Study:

• To review the current literature on the impact of AGP on cancer cells.
• To elucidate the role of reactive oxygen species (ROS) in AGP-induced cancer cell death.
• To explore the potential of AGP as a safe and effective anticancer therapy by understanding its cellular signaling mechanisms.

Main Methods:

• Literature review of existing studies on atmospheric gas plasmas and cancer therapy.
• Analysis of proposed mechanisms involving reactive oxygen species (ROS) and cellular signaling pathways.
• Evaluation of the differential effects of ROS on normal versus cancerous cells.

Main Results:

• AGP generates reactive oxygen species (ROS) that induce cancer cell death by disrupting intracellular regulatory factors.
• Cancer cells, often deficient in tumor suppressors, exhibit impaired ROS signaling pathway regulation.
• Normal cells can mitigate ROS toxicity through metabolic adjustments, unlike many cancer cells.

Conclusions:

• AGP therapy shows potential for selective cancer cell killing, exploiting tumor-specific genetic defects.
• Understanding the interplay between ROS, cellular signaling, and metabolic pathways is crucial for optimizing AGP anticancer efficacy.
• AGP represents a promising avenue for developing safer and more effective cancer treatments.